Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 447

1.

Additional treatment with 2-Chloro-2-Deoxyadenosine (2-CDA) during consolidation in children with high risk acute myeloid leukemia does not improve survival.

Creutzig U, Dworzak MN, Zimmermann M, Bourquin JP, Gruhn B, Fleischhack G, Graf N, Klingebiel T, Kremens B, Lehrnbecher T, von Neuhoff C, Stackelberg A, Starý J, Reinhardt D.

Leukemia. 2015 Apr 14. doi: 10.1038/leu.2015.94. [Epub ahead of print] No abstract available.

PMID:
25869725
2.

Response to letter commenting on "Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)".

SIOP Renal Tumor Study Group (RTSG), van den Heuvel-Eibrink MM, Pritchard-Jones K, van Tinteren H, Graf N.

Eur J Cancer. 2015 May;51(8):995-6. doi: 10.1016/j.ejca.2015.03.006. Epub 2015 Mar 31. No abstract available.

PMID:
25840668
3.

Analysis of the molecular response of Pseudomonas putida KT2440 to the next-generation biofuel n-butanol.

Simon O, Klebensberger J, Mükschel B, Klaiber I, Graf N, Altenbuchner J, Huber A, Hauer B, Pfannstiel J.

J Proteomics. 2015 Mar 27;122:11-25. doi: 10.1016/j.jprot.2015.03.022. [Epub ahead of print]

PMID:
25829261
4.

Clinical and Molecular Characterization of Patients with Heterozygous Mutations in Wilms Tumor Suppressor Gene 1.

Lehnhardt A, Karnatz C, Ahlenstiel-Grunow T, Benz K, Benz MR, Budde K, Büscher AK, Fehr T, Feldkötter M, Graf N, Höcker B, Jungraithmayr T, Klaus G, Koehler B, Konrad M, Kranz B, Montoya CR, Müller D, Neuhaus TJ, Oh J, Pape L, Pohl M, Royer-Pokora B, Querfeld U, Schneppenheim R, Staude H, Spartà G, Timmermann K, Wilkening F, Wygoda S, Bergmann C, Kemper MJ.

Clin J Am Soc Nephrol. 2015 Mar 27. pii: CJN.10141014. [Epub ahead of print]

PMID:
25818337
5.

Bloodstream infection in paediatric cancer centres-leukaemia and relapsed malignancies are independent risk factors.

Ammann RA, Laws HJ, Schrey D, Ehlert K, Moser O, Dilloo D, Bode U, Wawer A, Schrauder A, Cario G, Laengler A, Graf N, Furtwängler R, Simon A.

Eur J Pediatr. 2015 May;174(5):675-86. doi: 10.1007/s00431-015-2525-5. Epub 2015 Mar 26.

PMID:
25804192
6.

Circulating serum miRNAs as potential biomarkers for nephroblastoma.

Ludwig N, Nourkami-Tutdibi N, Backes C, Lenhof HP, Graf N, Keller A, Meese E.

Pediatr Blood Cancer. 2015 Mar 18. doi: 10.1002/pbc.25481. [Epub ahead of print]

PMID:
25787821
7.

Multiple mechanisms of MYCN dysregulation in Wilms tumour.

Williams RD, Chagtai T, Alcaide-German M, Apps J, Wegert J, Popov S, Vujanic G, van Tinteren H, van den Heuvel-Eibrink MM, Kool M, de Kraker J, Gisselsson D, Graf N, Gessler M, Pritchard-Jones K.

Oncotarget. 2015 Mar 30;6(9):7232-43.

8.

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.

Senti G, von Moos S, Tay F, Graf N, Johansen P, Kündig TM.

Allergy. 2015 Feb 20. doi: 10.1111/all.12600. [Epub ahead of print]

PMID:
25704072
9.

Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.

Wegert J, Ishaque N, Vardapour R, Geörg C, Gu Z, Bieg M, Ziegler B, Bausenwein S, Nourkami N, Ludwig N, Keller A, Grimm C, Kneitz S, Williams RD, Chagtai T, Pritchard-Jones K, van Sluis P, Volckmann R, Koster J, Versteeg R, Acha T, O'Sullivan MJ, Bode PK, Niggli F, Tytgat GA, van Tinteren H, van den Heuvel-Eibrink MM, Meese E, Vokuhl C, Leuschner I, Graf N, Eils R, Pfister SM, Kool M, Gessler M.

Cancer Cell. 2015 Feb 9;27(2):298-311. doi: 10.1016/j.ccell.2015.01.002.

PMID:
25670083
10.

Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?

Koks CA, De Vleeschouwer S, Graf N, Van Gool SW.

J Cancer. 2015 Jan 15;6(3):203-17. doi: 10.7150/jca.10640. eCollection 2015. Review.

11.

Long-term remission of recurrent thrombotic thrombocytopenic purpura (TTP) after Rituximab in children and young adults.

Wieland I, Kentouche K, Jentzsch M, Lothschütz D, Graf N, Sykora KW.

Pediatr Blood Cancer. 2015 May;62(5):823-9. doi: 10.1002/pbc.25398. Epub 2015 Jan 13.

PMID:
25623397
12.

Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).

van den Heuvel-Eibrink MM, van Tinteren H, Bergeron C, Coulomb-L'Hermine A, de Camargo B, Leuschner I, Sandstedt B, Acha T, Godzinski J, Oldenburger F, Gooskens SL, de Kraker J, Vujanic GM, Pritchard-Jones K, Graf N.

Eur J Cancer. 2015 Mar;51(4):498-506. doi: 10.1016/j.ejca.2014.12.011. Epub 2015 Jan 12.

PMID:
25592561
13.

Use of immunohistochemistry for SSTR2A to support a diagnosis of phosphaturic mesenchymal tumour.

Clugston E, Gill AC, Graf N, Bonar F, Gill AJ.

Pathology. 2015 Feb;47(2):173-5. doi: 10.1097/PAT.0000000000000221. No abstract available.

PMID:
25551311
14.

Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG).

Mavinkurve-Groothuis AM, van den Heuvel-Eibrink MM, Tytgat GA, van Tinteren H, Vujanic G, Pritchard-Jones KL, Howell L, Graf N, Bergeron C, Acha T, Catania S, Spreafico F.

Pediatr Blood Cancer. 2015 Apr;62(4):598-602. doi: 10.1002/pbc.25357. Epub 2014 Dec 29.

PMID:
25546733
15.

New insights into the genetics of glioblastoma multiforme by familial exome sequencing.

Backes C, Harz C, Fischer U, Schmitt J, Ludwig N, Petersen BS, Mueller SC, Kim YJ, Wolf NM, Katus HA, Meder B, Furtwängler R, Franke A, Bohle R, Henn W, Graf N, Keller A, Meese E.

Oncotarget. 2015 Mar 20;6(8):5918-31.

16.

Development of a scoliotic spine model for biomechanical in vitro studies.

Wilke HJ, Mathes B, Midderhoff S, Graf N.

Clin Biomech (Bristol, Avon). 2015 Feb;30(2):182-7. doi: 10.1016/j.clinbiomech.2014.12.002. Epub 2014 Dec 9.

PMID:
25533272
17.

Current concepts in surgery for Wilms tumor--the risk and function-adapted strategy.

Godzinski J, Graf N, Audry G.

Eur J Pediatr Surg. 2014 Dec;24(6):457-60. doi: 10.1055/s-0034-1396425. Epub 2014 Dec 5.

PMID:
25478666
18.

Minimally invasive nephrectomy for Wilms tumors in children - data from SIOP 2001.

Warmann SW, Godzinski J, van Tinteren H, Heij H, Powis M, Sandstedt B, Graf N, Fuchs J; Surgical Panel of the SIOP Renal Tumor Strategy Group.

J Pediatr Surg. 2014 Nov;49(11):1544-8. doi: 10.1016/j.jpedsurg.2014.06.005. Epub 2014 Oct 1.

PMID:
25475791
19.

Where no guideline has gone before: retrospective analysis of resuscitation in the 24th century.

Hörburger D, Haslinger J, Bickel H, Graf N, Schober A, Testori C, Weiser C, Sterz F, Haugk M.

Resuscitation. 2014 Dec;85(12):1790-4.

PMID:
25457378
20.

Two-year outcome of repeat trabeculectomy with mitomycin C in primary open-angle and PEX glaucoma.

Meyer LM, Graf NE, Philipp S, Fischer MT, Haller K, Distelmaier P, Schönfeld CL.

Eur J Ophthalmol. 2015 Apr 22;25(3):185-91. doi: 10.5301/ejo.5000542. Epub 2014 Dec 1.

PMID:
25449638
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk